0001437749-20-014008.txt : 20200626 0001437749-20-014008.hdr.sgml : 20200626 20200626165115 ACCESSION NUMBER: 0001437749-20-014008 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20200624 FILED AS OF DATE: 20200626 DATE AS OF CHANGE: 20200626 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Gagnon Suzanne CENTRAL INDEX KEY: 0001652855 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-55242 FILM NUMBER: 20994715 MAIL ADDRESS: STREET 1: 712 VISTA BLVD #305 CITY: WACONIA STATE: MN ZIP: 55387 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Sun BioPharma, Inc. CENTRAL INDEX KEY: 0001029125 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 870543922 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 712 VISTA BLVD #305 CITY: WACONIA STATE: MN ZIP: 55387 BUSINESS PHONE: 9524791196 MAIL ADDRESS: STREET 1: 712 VISTA BLVD #305 CITY: WACONIA STATE: MN ZIP: 55387 FORMER COMPANY: FORMER CONFORMED NAME: Cimarron Medical, Inc. DATE OF NAME CHANGE: 20150602 FORMER COMPANY: FORMER CONFORMED NAME: CIMARRON SOFTWARE INC DATE OF NAME CHANGE: 19961217 4 1 rdgdoc.xml FORM 4 X0306 4 2020-06-24 0001029125 Sun BioPharma, Inc. SNBP 0001652855 Gagnon Suzanne 712 VISTA BLVD #305 WACONIA MN 55387 1 Employee Stock Option (right to buy) 4.98 2020-06-24 4 A 0 40000 0 A 2030-06-24 Common Stock 40000 40000 D Immediately exercisable as to 25% of the shares and scheduled to vest with respect to 25% of the shares on each of June 24, 2021, June 24, 2022 and June 24, 2023. /s/ Joshua L. Colburn, Attorney-in-Fact 2020-06-26